MATURATION AND DESICCATION OF GYMNOSPERM SOMATIC EMBRYOS
    44.
    发明授权
    MATURATION AND DESICCATION OF GYMNOSPERM SOMATIC EMBRYOS 失效
    脱水裸子植物体胚

    公开(公告)号:EP0618766B1

    公开(公告)日:2001-06-20

    申请号:EP93900142.6

    申请日:1992-12-18

    CPC classification number: A01H7/00 A01H4/006

    Abstract: A desiccated mature gymnosperm somatic embryo characterized by having a moisture content which is lower than the moisture content of its corresponding zygotic embryo and a dry weight and per embryo lipid content which are higher than the lipid content and dry weight of its corresponding gymnosperm zygotic embryo. Preferred desiccated gymnosperm somatic embryos are conifer somatic embryos having a moisture content ranging between 10 and 55 %. Also within the scope of the invention is a method for producing desiccated somatic embryos. The method comprises developing immature embryos in a medium comprising at least one non-permeating water stress agent, a metabolizable carbon source and a growth regulator having an influence on embryo development for a period of time sufficient to yield the recovery of mature somatic embryos having a moisture content which is lower than the moisture content of corresponding zygotic embryos. The method can optionally include a secondary desiccation treatment to further reduce the moisture content of the embryos.

    BOVINE ADENOVIRUS TYPE 3 GENOME
    46.
    发明公开
    BOVINE ADENOVIRUS TYPE 3 GENOME 失效
    用于生产重组载体RINDERADENOVIRUS

    公开(公告)号:EP0998576A2

    公开(公告)日:2000-05-10

    申请号:EP98930594.1

    申请日:1998-06-23

    Abstract: In one embodiment, the present invention relates to novel bovine adenovirus expression vector systems which utilize the following regions of the bovine adenovirus genome: nucleotides 4,092-5,234; nucleotides 5,892-17,735; nucleotides 21,198-26,033 and nucleotides 31,133-34,445. These regions can be used, among other things, for insertion of foreign sequences, for provision of DNA control sequences including transcriptional and translational regulatory sequences, or for diagnostic purposes to detect the presence of viral nucleic acids or proteins encoded by these regions, in a subject or biological sample. In another embodiment, the present invention relates to novel methods for the construction, isolation and propagation of recombinant bovine adenovirus (BAV) with deletions (and optionally insertions of heterologous sequence) in the E3 region. Recombinant BAV containing insertions of genes encoding protective determinants of a pathogen stimulate enhanced systemic and mucosal immune responses and protect host animals against challenge by the pathogen.

    COMPOSITIONS AND TREATMENTS FOR PNEUMONIA IN ANIMALS
    47.
    发明公开
    COMPOSITIONS AND TREATMENTS FOR PNEUMONIA IN ANIMALS 失效
    筹备工作和肺炎动物的治疗。

    公开(公告)号:EP0527724A1

    公开(公告)日:1993-02-24

    申请号:EP90906831.0

    申请日:1990-05-25

    CPC classification number: A61K39/102 A61K39/00 C07K14/285

    Abstract: L'invention a pour objet de nouvelles protéines et des antigènes de sous-groupes provenant de P. haemolytica, s'utilisant pour stimuler l'immunité contre des maladies respiratoires comme la pneumonie, y compris la pneumonie causée par le transport. Les antigènes de sous-groupes comprennent des séquences immunogènes amino-acides de la protéine periphérifine de P. haemolytica, de la proteine réceptrice de plasmine de P. haemolytica et de la protéine de membrane extérieure 50 K de P. haemolytica ainsi que de la leucotoxine de P. haemolytica. Les antigènes peuvent s'utiliser dans une composition de vaccin, soit seuls soit en combinaison. L'invention se rapporte également à des procédés de vaccination ainsi qu'à des procédés de production des antigènes de sous-groupes

Patent Agency Ranking